LIVIVO - Search results -

Search results

Result 1 - 10 of total 19

Search options

Article: Efficacy of Fosfomycin-Containing Regimens for Treatment of Bacteremia Due to Pan-Drug Resistant

Assimakopoulos, Stelios F / Karamouzos, Vassilis / Eleftheriotis, Gerasimos / Lagadinou, Maria / Bartzavali, Christina / Kolonitsiou, Fevronia / Paliogianni, Fotini / Fligou, Fotini / Marangos, Markos

Pathogens (Basel, Switzerland)

2023 Volume 12, Issue 2

Abstract: Acinetobacter ... ...

Abstract	Acinetobacter baumannii
Language	English
Publishing date	2023-02-09
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2695572-6
ISSN	2076-0817
ISSN	2076-0817
DOI	10.3390/pathogens12020286
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Laboratory Surveillance of

Spiliopoulou, Anastasia / Giannopoulou, Ioanna / Assimakopoulos, Stelios F / Jelastopulu, Eleni / Bartzavali, Christina / Marangos, Markos / Paliogianni, Fotini / Kolonitsiou, Fevronia

Tropical medicine and infectious disease

2023 Volume 8, Issue 11

Abstract: Multidrug- ... ...

Abstract	Multidrug-resistant
Language	English
Publishing date	2023-11-19
Publishing country	Switzerland
Document type	Journal Article
ISSN	2414-6366
ISSN (online)	2414-6366
DOI	10.3390/tropicalmed8110503
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: A Seven-Year Microbiological and Molecular Study of Bacteremias Due to Carbapenemase-Producing

Papadimitriou-Olivgeris, Matthaios / Bartzavali, Christina / Karachalias, Eleftherios / Spiliopoulou, Anastasia / Tsiata, Ekaterini / Siakallis, Georgios / Assimakopoulos, Stelios F / Kolonitsiou, Fevronia / Marangos, Markos

Antibiotics (Basel, Switzerland)

2022 Volume 11, Issue 10

Abstract: Background: Ceftazidime/avibactam (CZA) is a new option for the treatment of KPC-producing Klebsiella pneumoniae. The aim of this study was to determine resistance patterns and carbapenemase genes among K. pneumoniae (CP-Kp) bacteremic isolates before ... ...

Abstract	Background: Ceftazidime/avibactam (CZA) is a new option for the treatment of KPC-producing Klebsiella pneumoniae. The aim of this study was to determine resistance patterns and carbapenemase genes among K. pneumoniae (CP-Kp) bacteremic isolates before and after CZA introduction. Methods: K. pneumoniae from blood cultures of patients being treated in a Greek university hospital during 2015−21 were included. PCR for blaKPC, blaVIM, blaNDM and blaOXA-48 genes was performed. Results: Among 912 K. pneumoniae bacteremias: 725 (79.5%) were due to carbapenemase-producing isolates; 488 (67.3%) carried blaKPC; 108 (14.9%) blaVIM; 100 (13.8%) blaNDM; and 29 (4%) carried a combination of blaKPC, blaVIM or blaNDM. The incidence of CP-Kp bacteremias was 59 per 100,000 patient-days. The incidence of CP-Kp changed from a downward pre-CZA trend to an upward trend in the CZA period (p = 0.007). BSIs due to KPC-producing isolates showed a continuous downward trend in the pre-CZA and CZA periods (p = 0.067), while BSIs due to isolates carrying blaVIM or blaNDM changed from a downward trend in the pre-CZA to an upward trend in the CZA period (p < 0.001). Conclusions: An abrupt change in the epidemiology of CP-Kp was observed in 2018, due to the re-emergence of VIM-producing isolates after the suppression of KPC-producing ones via the use of CZA.
Language	English
Publishing date	2022-10-14
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2681345-2
ISSN	2079-6382
ISSN	2079-6382
DOI	10.3390/antibiotics11101414
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Increased incidence of candidemia in critically ill patients during the Coronavirus Disease 2019 (COVID-19) pandemic.

Papadimitriou-Olivgeris, Matthaios / Kolonitsiou, Fevronia / Kefala, Sotiria / Spiliopoulou, Anastasia / Aretha, Diamanto / Bartzavali, Christina / Siapika, Argyro / Marangos, Markos / Fligou, Fotini

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

2022 Volume 26, Issue 2, Page(s) 102353

Abstract: Background: Patients with severe Coronavirus Disease 2019 (COVID-19) are treated with corticosteroids.: Aim: We aimed to evaluate the role of corticosteroid treatment in candidemia development during the COVID-19 pandemic.: Methods: This ... ...

Abstract	Background: Patients with severe Coronavirus Disease 2019 (COVID-19) are treated with corticosteroids. Aim: We aimed to evaluate the role of corticosteroid treatment in candidemia development during the COVID-19 pandemic. Methods: This retrospective study was conducted in a Greek ICU, from 2010 to August 2021, encompassing a pre-pandemic and a pandemic period (pandemic period: April 2020 to August 2021). All adult patients with candidemia were included. Results: During the study period, 3,572 patients were admitted to the ICU, 339 patients during the pandemic period, of whom 196 were SARS-CoV-2-positive. In total, 281 candidemia episodes were observed in 239 patients, 114 in the pandemic period. The majority of candidemias in both periods were catheter-related (161; 50.4%). The incidence of candidemia in the pre-pandemic period was 5.2 episodes per 100 admissions, while in the pandemic period was 33.6 (p < 0.001). In the pandemic period, the incidence among COVID-19 patients was 38.8 episodes per 100 admissions, while in patients without COVID-19 incidence was 26.6 (p = 0.019). Corticosteroid administration in both periods was not associated with increased candidemia incidence. Conclusions: A significant increase of candidemia incidence was observed during the pandemic period in patients with and without COVID-19. This increase cannot be solely attributed to immunosuppression (corticosteroids, tocilizumab) of severe COVID-19 patients, but also to increased workload of medical and nursing staff.
MeSH term(s)	Adrenal Cortex Hormones/adverse effects ; Adult ; COVID-19 ; Candidemia/epidemiology ; Critical Illness/epidemiology ; Humans ; Incidence ; Intensive Care Units ; Pandemics ; Retrospective Studies ; SARS-CoV-2
Chemical Substances	Adrenal Cortex Hormones
Language	English
Publishing date	2022-04-25
Publishing country	Brazil
Document type	Journal Article
ZDB-ID	2041400-6
ISSN	1678-4391 ; 1413-8670
ISSN (online)	1678-4391
ISSN	1413-8670
DOI	10.1016/j.bjid.2022.102353
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5633: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Mortality of Pandrug-Resistant

Papadimitriou-Olivgeris, Matthaios / Bartzavali, Christina / Georgakopoulou, Alexandra / Kolonitsiou, Fevronia / Papamichail, Chrisavgi / Spiliopoulou, Iris / Christofidou, Myrto / Fligou, Fotini / Marangos, Markos

Antibiotics (Basel, Switzerland)

2021 Volume 10, Issue 1

Abstract: Background: The increased frequency of bacteraemias caused by pandrug-resistant : Methods: Patients with monomicrobial bacteraemia due to PDR-Kp were included. : Results: Among 115 PDR-Kp bacteraemias, the majority of infections were primary ... ...

Abstract	Background: The increased frequency of bacteraemias caused by pandrug-resistant Methods: Patients with monomicrobial bacteraemia due to PDR-Kp were included. Results: Among 115 PDR-Kp bacteraemias, the majority of infections were primary bacteraemias (53; 46.1%), followed by catheter-related (35; 30.4%). All isolates were resistant to tested antimicrobials. Conclusions: Mortality of PDR-Kp bloodstream infections was high. Administration of at least three antimicrobials might be beneficial for infections in critically ill patients caused by such pathogens.
Language	English
Publishing date	2021-01-15
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2681345-2
ISSN	2079-6382
ISSN	2079-6382
DOI	10.3390/antibiotics10010076
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: External validation of INCREMENT-CPE score in a retrospective cohort of carbapenemase-producing Klebsiella pneumoniae bloodstream infections in critically ill patients.

Papadimitriou-Olivgeris, Matthaios / Bartzavali, Christina / Georgakopoulou, Alexandra / Kolonitsiou, Fevronia / Mplani, Virginia / Spiliopoulou, Iris / Christofidou, Myrto / Fligou, Fotini / Marangos, Markos

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

2021 Volume 27, Issue 6, Page(s) 915.e1–915.e3

Abstract: Objectives: Our aim was to validate the INCREMENT-CPE score (ICS) in patients hospitalized in the intensive care unit (ICU) with bacteraemia due to carbapenemase-producing Klebsiella pneumoniae (CP-Kp).: Methods: The study was conducted in the ICU of ...

Abstract	Objectives: Our aim was to validate the INCREMENT-CPE score (ICS) in patients hospitalized in the intensive care unit (ICU) with bacteraemia due to carbapenemase-producing Klebsiella pneumoniae (CP-Kp). Methods: The study was conducted in the ICU of the University General Hospital of Patras, Greece, during a 10-year period (2010-2019). Patients with monomicrobial bacteraemia due to CP-Kp were included. Primary outcome was 14-day mortality. MICs of meropenem, tigecycline, fosfomycin and ceftazidime/avibactam were determined by Etest, whereas for colistin the broth microdilution method was applied. PCR for bla Results: Among 384 CP-Kp bacteraemias, most were primary (166, 43.2%) followed by catheter-related (143, 37.2%). Most isolates carried bla Conclusions: ICS showed predictive efficacy similar to that of the SAPS II, SOFA and Pitt bacteraemia scores.
MeSH term(s)	Anti-Bacterial Agents/pharmacology ; Bacteremia/drug therapy ; Bacteremia/microbiology ; Bacterial Proteins/genetics ; Bacterial Proteins/metabolism ; Carbapenems/pharmacology ; Cohort Studies ; Critical Illness ; Drug Resistance, Multiple, Bacterial ; Humans ; Klebsiella Infections/microbiology ; Klebsiella Infections/pathology ; Klebsiella pneumoniae/drug effects ; Klebsiella pneumoniae/enzymology ; Microbial Sensitivity Tests ; Reproducibility of Results ; Retrospective Studies ; Sepsis/microbiology ; Sepsis/pathology ; beta-Lactamases/genetics ; beta-Lactamases/metabolism
Chemical Substances	Anti-Bacterial Agents ; Bacterial Proteins ; Carbapenems ; beta-Lactamases (EC 3.5.2.6) ; carbapenemase (EC 3.5.2.6)
Language	English
Publishing date	2021-01-12
Publishing country	England
Document type	Journal Article
ZDB-ID	1328418-6
ISSN	1469-0691 ; 1470-9465 ; 1198-743X
ISSN (online)	1469-0691
ISSN	1470-9465 ; 1198-743X
DOI	10.1016/j.cmi.2021.01.001
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4541: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 284: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Impact of Tigecycline's MIC in the Outcome of Critically Ill Patients with Carbapenemase-Producing

Papadimitriou-Olivgeris, Matthaios / Bartzavali, Christina / Nikolopoulou, Alexandra / Kolonitsiou, Fevronia / Mplani, Virginia / Spiliopoulou, Iris / Christofidou, Myrto / Fligou, Fotini / Marangos, Markos

Antibiotics (Basel, Switzerland)

2020 Volume 9, Issue 11

Abstract: Background: Tigecycline is a therapeutic option for carbapenemase-producing : Methods: Patients with monomicrobial bacteraemia due to CP-Kp that received appropriate targeted monotherapy or no appropriate treatment were included. Primary outcome was ... ...

Abstract	Background: Tigecycline is a therapeutic option for carbapenemase-producing Methods: Patients with monomicrobial bacteraemia due to CP-Kp that received appropriate targeted monotherapy or no appropriate treatment were included. Primary outcome was 30-day mortality. MICs of meropenem, tigecycline, and ceftazidime/avibactam were determined by Etest, whereas for colistin, the broth microdilution method was applied. PCR for Results: Among 302 CP-Kp bacteraemias, 32 isolates (10.6%) showed MICs of tigecycline ≤ 0.5 mg/L, whereas 177 (58.6%) showed MICs that were 0.75-2 mg/L. Colistin and aminoglycoside susceptibility was observed in 43.0% and 23.8% of isolates, respectively. The majority of isolates carried Conclusion: Tigecycline monotherapy was as efficacious as other antimicrobials in the treatment of bloodstream infections due to CP-Kp isolates with a tigecycline's MIC ≤ 0.5 mg/L.
Language	English
Publishing date	2020-11-19
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2681345-2
ISSN	2079-6382
ISSN	2079-6382
DOI	10.3390/antibiotics9110828
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Evaluation of a commercial PCR test for the diagnosis of dermatophyte nail infections.

Spiliopoulou, Anastasia / Bartzavali, Christina / Jelastopulu, Eleni / Anastassiou, Evangelos D / Christofidou, Myrto

Journal of medical microbiology

2014 Volume 64, Issue Pt 1, Page(s) 25–31

Abstract: Tinea unguium, known as onychomycosis, is a dermatophyte infection of nails with worldwide distribution. Conventional methods for detecting fungi in nail specimens are either non-specific (microscopy) or insensitive (culture). PCR has been used to ... ...

Abstract	Tinea unguium, known as onychomycosis, is a dermatophyte infection of nails with worldwide distribution. Conventional methods for detecting fungi in nail specimens are either non-specific (microscopy) or insensitive (culture). PCR has been used to improve sensitivity in detecting the causative fungi in nail specimens from patients with suspected onychomycosis. Results of a commercial multiplex PCR for the detection of dermatophytes, especially Trichophyton rubrum (the main dermatophyte implicated), as compared to conventional methods are presented. A total of 418 nail scrapings obtained from dermatological outpatients were handled in the Laboratory of Microbiology between May 2010 and May 2013. Among them, multiplex PCR detected 126 (30.1 %) dermatophyte-positive samples, whereas culture revealed 44 (10.5 %). Direct microscopy revealed 63 (15.1 %) positive specimens. T. rubrum was identified in 116 out of 126 (92 %) positive PCR samples and 40 out of 44 (91 %) dermatophyte-positive cultures. Implementation of PCR increased species-specific detection of dermatophytes by 21.1 %, leading to a threefold increase as compared to culture alone. Multiplex PCR offers a time-saving diagnostic tool for tinea unguium and augments laboratory assistance to clinical evaluation for proper treatment.
MeSH term(s)	Aged ; Aged, 80 and over ; Arthrodermataceae/classification ; Arthrodermataceae/genetics ; Arthrodermataceae/isolation & purification ; Female ; Humans ; Male ; Microbiological Techniques/methods ; Middle Aged ; Molecular Diagnostic Techniques/methods ; Multiplex Polymerase Chain Reaction/methods ; Mycology/methods ; Onychomycosis/diagnosis ; Onychomycosis/microbiology ; Sensitivity and Specificity
Language	English
Publishing date	2014-11-23
Publishing country	England
Document type	Comparative Study ; Evaluation Study ; Journal Article
ZDB-ID	218356-0
ISSN	1473-5644 ; 0022-2615
ISSN (online)	1473-5644
ISSN	0022-2615
DOI	10.1099/jmm.0.079962-0
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 634: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam.

Papadimitriou-Olivgeris, Matthaios / Bartzavali, Christina / Lambropoulou, Anastasia / Solomou, Anastasia / Tsiata, Ekaterini / Anastassiou, Evangelos D / Fligou, Fotini / Marangos, Markos / Spiliopoulou, Iris / Christofidou, Myrto

The Journal of antimicrobial chemotherapy

2019 Volume 74, Issue 7, Page(s) 2051–2054

Abstract: Objectives: Our aim was to determine the epidemiology of bloodstream infections (BSIs) by carbapenemase-producing Klebsiella pneumoniae (CP-Kp) after the introduction of ceftazidime/avibactam in January 2018 among ICU patients.: Patients and methods: ...

Abstract	Objectives: Our aim was to determine the epidemiology of bloodstream infections (BSIs) by carbapenemase-producing Klebsiella pneumoniae (CP-Kp) after the introduction of ceftazidime/avibactam in January 2018 among ICU patients. Patients and methods: All patients hospitalized at the ICU of the University General Hospital of Patras, Greece with CP-Kp BSI during 2015-18 were included. MICs of meropenem, fosfomycin, tigecycline and ceftazidime/avibactam (only for isolates from 2018) were determined by Etest, whereas for colistin, the broth microdilution method was applied. All isolates were tested by PCR for the presence of blaKPC, blaVIM, blaNDM and blaOXA-48 genes. Results: Among 170 BSIs due to CP-Kp (2015-18), 132 (78%) were caused by isolates carrying blaKPC (4 ceftazidime/avibactam-resistant), 17 blaVIM (10%), 16 blaNDM (9%) and 5 carrying both blaKPC and blaVIM (3%). From 2015 to 2017 (125 BSIs), KPC-producing strains (110; 88%) predominated, followed by NDM-producing strains (15; 12%), whereas no VIM-producing strain was isolated. Among the 45 BSIs in 2018, 22 (49%) were due to isolates carrying blaKPC (4 ceftazidime/avibactam resistant), followed by 17 (38%) carrying blaVIM, 5 (11%) carrying both blaKPC and blaVIM, and 1 isolate carrying blaNDM (2%). MBLs were more frequent in 2018 compared with 2015-17 (51% versus 12%; P < 0.001). Multivariate analysis found that prior administration of ceftazidime/avibactam (P = 0.014; OR 16.7, 95% CI 1.8-158.6) was independently associated with the development of BSI due to ceftazidime/avibactam-resistant isolates. Conclusions: Widespread ceftazidime/avibactam use may lead to a change in the palette of carbapenemases by replacing KPC with MBL-producing isolates.
MeSH term(s)	Adult ; Aged ; Azabicyclo Compounds/pharmacology ; Azabicyclo Compounds/therapeutic use ; Bacteremia ; Bacterial Proteins/biosynthesis ; Bacterial Proteins/genetics ; Carbapenem-Resistant Enterobacteriaceae ; Ceftazidime/pharmacology ; Ceftazidime/therapeutic use ; Cross Infection ; Disease Susceptibility ; Drug Combinations ; Female ; Greece/epidemiology ; Humans ; Intensive Care Units ; Klebsiella Infections/drug therapy ; Klebsiella Infections/epidemiology ; Klebsiella Infections/microbiology ; Klebsiella pneumoniae/drug effects ; Klebsiella pneumoniae/genetics ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Public Health Surveillance ; beta-Lactam Resistance ; beta-Lactamases/biosynthesis ; beta-Lactamases/genetics
Chemical Substances	Azabicyclo Compounds ; Bacterial Proteins ; Drug Combinations ; avibactam, ceftazidime drug combination ; Ceftazidime (9M416Z9QNR) ; beta-Lactamases (EC 3.5.2.6) ; carbapenemase (EC 3.5.2.6)
Language	English
Publishing date	2019-05-14
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	191709-2
ISSN	1460-2091 ; 0305-7453
ISSN (online)	1460-2091
ISSN	0305-7453
DOI	10.1093/jac/dkz125
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1197: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 124: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: The first NDM metallo-β-lactamase producing Klebsiella pneumoniae isolate in a University Hospital of Southwestern Greece.

Spyropoulou, Aikaterini / Bartzavali, Christina / Vamvakopoulou, Sophia / Marangos, Markos / Anastassiou, Evangelos D / Spiliopoulou, Iris / Christofidou, Myrto

Journal of chemotherapy (Florence, Italy)

2016 Volume 28, Issue 4, Page(s) 350–351

MeSH term(s)	Aged ; Bacteremia/diagnosis ; Bacteremia/microbiology ; Drug Resistance, Bacterial ; Greece ; Hospitals, Teaching ; Humans ; Klebsiella Infections/diagnosis ; Klebsiella Infections/microbiology ; Klebsiella pneumoniae/drug effects ; Klebsiella pneumoniae/enzymology ; Klebsiella pneumoniae/genetics ; Klebsiella pneumoniae/isolation & purification ; Male ; beta-Lactamases/genetics ; beta-Lactamases/metabolism
Chemical Substances	beta-Lactamases (EC 3.5.2.6)
Language	English
Publishing date	2016-08
Publishing country	England
Document type	Case Reports ; Letter
ZDB-ID	1036294-0
ISSN	1973-9478 ; 1120-009X
ISSN (online)	1973-9478
ISSN	1120-009X
DOI	10.1179/1973947815Y.0000000003
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2701: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 387: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito